Kymera Therapeutics
Kymera Therapeutics Logo
About Kymera Therapeutics
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's natural protein degradation system. The company is advancing a pipeline of first-in-class oral medicines targeting immunology and inflammatory diseases, including programs for IRAK4, STAT6, and TYK2. Kymera aims to address critical health problems by developing new treatment paradigms through targeted protein degradation.
Address
200 Arsenal Yards Boulevard, Suite 230
Watertown, 02472
United States
Year founded
2015
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
